You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

29 November 2021

Find information about advertising COVID-19 rapid tests.

24 November 2021

A list of self-tests that are approved in Australia

22 November 2021
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
8 November 2021
Updated guidance clarifying the interaction between TGA and AHPRA advertising guidelines.
3 November 2021
The TGA is undertaking a post-market review of all Point of Care and Laboratory tests included in the ARTG, which are intended to identify patients with COVID-19, to ensure they can detect the emerging SARS-CoV-2 genetic variants and remain accurate.
2 November 2021

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

1 November 2021

COVID-19 vaccine batch release information is now available.

14 October 2021

Find information about advertising COVID-19 rapid tests.

20 September 2021
Answers to frequently asked questions in relation to rapid antigen tests.
27 August 2021
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us